blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3286338

EP3286338 - AMPLIFICATION WITH PRIMERS OF LIMITED NUCLEOTIDE COMPOSITION [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  29.09.2023
Database last updated on 03.09.2024
FormerGrant of patent is intended
Status updated on  15.05.2023
FormerExamination is in progress
Status updated on  25.03.2023
FormerGrant of patent is intended
Status updated on  15.11.2022
FormerExamination is in progress
Status updated on  11.03.2022
FormerRequest for examination was made
Status updated on  26.01.2018
FormerThe international publication has been made
Status updated on  01.11.2016
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): SK		published on 04.09.2024 [2024/36]
Applicant(s)For all designated states
ATILA BIOSYSTEMS INCORPORATED
4236 Darlington Court
Palo Alto, CA 94306 / US
[2023/43]
Former [2022/41]For all designated states
Atila Biosystems Incorporated
4236 Darlington Court
Palo Alto, CA 94306 / US
Former [2018/09]For all designated states
Atila Biosystems, Inc.
4236 Darlington Court
Palo Alto, CA 94306 / US
Inventor(s)01 / WANG, Youxiang
Sunnyvale, CA 94085 / US
02 / YANG, Zhijie
Sunnyvale, CA 94085 / US
03 / CHEN, Xin
Sunnyvale, CA 94085 / US
 [2023/43]
Former [2018/09]01 / WANG, Youxiang
740 Sierra Vista Avenue
Unite E
Maountain View, CA 94043 / US
02 / YANG, Zhijie
740 Sierra Vista Avenue
Unite E
Mountain View, CA 94043 / US
03 / CHEN, Xin
740 Sierra Vista Avenue
Unite E
Mountain View, CA 94043 / US
Representative(s)Patent Boutique LLP
10A Printing House Yard
Hackney Road
London E2 7PR / GB
[2023/44]
Former [2018/09]Patent Boutique LLP
Aldgate Tower
2 Leman Street
London E1 8FA / GB
Application number, filing date16784032.122.04.2016
[2018/09]
WO2016US29054
Priority number, dateUS201562152756P24.04.2015         Original published format: US 201562152756 P
[2018/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016172632
Date:27.10.2016
Language:EN
[2016/43]
Type: A2 Application without search report 
No.:EP3286338
Date:28.02.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 27.10.2016 takes the place of the publication of the European patent application.
[2018/09]
Type: B1 Patent specification 
No.:EP3286338
Date:01.11.2023
Language:EN
[2023/44]
Search report(s)International search report - published on:US12.01.2017
(Supplementary) European search report - dispatched on:EP16.11.2018
ClassificationIPC:C12Q1/6848
[2018/51]
CPC:
C12Q1/6848 (EP,CN,US); C12Q2525/101 (US); C12Q2525/143 (US);
C12Q2525/161 (US); C12Q2525/301 (US); C12Q2527/137 (US);
C12Q2527/143 (US); C12Q2565/107 (US) (-)
C-Set:
C12Q1/6848, C12Q2525/101, C12Q2531/113, C12Q2537/157, C12Q2537/159 (CN,EP,US)
Former IPC [2018/09]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/09]  
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:AMPLIFIKATION MIT PRIMERN EINER BEGRENZTEN NUKLEOTIDZUSAMMENSETZUNG[2018/09]
English:AMPLIFICATION WITH PRIMERS OF LIMITED NUCLEOTIDE COMPOSITION[2018/09]
French:AMPLIFICATION AVEC DES AMORCES DE COMPOSITION NUCLÉOTIDIQUE LIMITÉE[2018/09]
Entry into regional phase20.11.2017National basic fee paid 
20.11.2017Search fee paid 
20.11.2017Designation fee(s) paid 
20.11.2017Examination fee paid 
Examination procedure20.11.2017Examination requested  [2018/09]
20.11.2017Date on which the examining division has become responsible
12.06.2019Amendment by applicant (claims and/or description)
11.03.2022Despatch of a communication from the examining division (Time limit: M06)
07.09.2022Reply to a communication from the examining division
16.11.2022Communication of intention to grant the patent
24.03.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.05.2023Communication of intention to grant the patent
25.09.2023Fee for grant paid
25.09.2023Fee for publishing/printing paid
25.09.2023Receipt of the translation of the claim(s)
Fees paidRenewal fee
11.04.2018Renewal fee patent year 03
15.04.2019Renewal fee patent year 04
31.03.2020Renewal fee patent year 05
15.04.2021Renewal fee patent year 06
27.04.2022Renewal fee patent year 07
23.02.2023Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ01.11.2023
HR01.11.2023
PL01.11.2023
RO01.11.2023
RS01.11.2023
SK01.11.2023
SM01.11.2023
NO01.02.2024
GR02.02.2024
IS01.03.2024
[2024/36]
Former [2024/35]CZ01.11.2023
HR01.11.2023
PL01.11.2023
RO01.11.2023
RS01.11.2023
SM01.11.2023
NO01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/33]HR01.11.2023
PL01.11.2023
RS01.11.2023
SM01.11.2023
NO01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/25]HR01.11.2023
PL01.11.2023
RS01.11.2023
NO01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/24]HR01.11.2023
RS01.11.2023
NO01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/20]GR02.02.2024
IS01.03.2024
Documents cited:Search[A]WO2006058393  (HUMAN GENETIC SIGNATURES PTY [AU], et al) [A] 1-17* table 2 *;
 [Y]US2011294129  (LAAYOUN ALI [FR], et al) [Y] 4 * pages 6,9 *;
 [XYI]  - BRAUN A ET AL, "DETECTING CFTR GENE MUTATIONS BY USING PRIMER OLIGO BASE EXTENSION AND MASS SPECTROMETRY", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, (19970101), vol. 43, no. 7, ISSN 0009-9147, pages 1151 - 1158, XP001019094 [X] 1-3,5-7,11,17 * page 1151 - page 1152 * [Y] 4 [I] 1-3,5-17
 [Y]  - FANYI ZENG ET AL, "Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients", HUMAN MUTATION, (20080101), vol. 29, no. 1, doi:10.1002/humu.20613, ISSN 1059-7794, pages 190 - 197, XP055034061 [Y] 4 * page 191, column r *

DOI:   http://dx.doi.org/10.1002/humu.20613
International search[Y]US2009036315  (LABGOLD MARC R [US], et al) [Y] 69-70 * para [0015], [0064], [0109] *;
 [XY]US2013115595  (HANTASH FERAS [US], et al) [X] 1-4, 13-14, 75-79, 80-82 * para [0008], [0010], [0057], [0067], [0138], [0148], [0169], [0187], Table 7 * [Y] 58-60, 69-70;
 [Y]US2014065613  (BORMANN CHUNG CHRISTINA [US], et al) [Y] 60* para [0003], [0062] *;
 [X]US2014228254  (ADESSI CELINE [FR], et al) [X] 61-64 * para [0025], [0157], [0158] *;
 [Y]  - VAN HARMELEN et al., "Increased Adipose Angiotensinogen Gene Expression in Human Obesity", OBESITY RESEARCH, (20000700), vol. 8, no. 4, pages 337 - 341, XP055345379 [Y] 58-60 * ; pg 338, col 1, para 2 *

DOI:   http://dx.doi.org/10.1038/oby.2000.40
ExaminationWO2010021702
by applicantUS4683202
 WO9208800
 US5270184
 US5310652
 US5322770
 US5338671
 US5399491
 US5409818
 US5411876
 US5418149
 US5422252
 US5437990
 US5455166
 US5470723
 EP0684315
 US5480784
 WO9604404
 US5539082
 US5538848
 US5677152
 US5773258
 US5854033
 US5925517
 US6001611
 US6130038
 US6174670
 US6268490
 US6326145
 US6329144
 US6410278
 US6635427
 US6670461
 US2004058378
 US7011944
 US7112423
 US2007254304
 US2009017453
 WO2010021702
 US2011294129
 US8105778
 US8658366
    - SAIKI et al., Science (New York, N.Y.), (19850000), vol. 230, no. 4732, pages 1350 - 1354
    - CHOURUSSELLBIRCHRAYMONDBLOCH, Nucleic Acids Research, (19920000), vol. 20, no. 7, pages 1717 - 1723
    - KWOH et al., Proceedings of the National Academy of Sciences of the United States of America, (19890000), vol. 86, no. 4, pages 1173 - 1177
    - GUATELLI et al., Proceedings of the National Academy of Sciences of the United States of America, (19900000), vol. 87, no. 5, pages 1874 - 1878
    - LAFFLERCARRINOMARSHALL, Annales De Biologie Clinique, (19930000), vol. 51, no. 9, pages 821 - 826
    - DUCKALVARADO-URBINABURDICKCOLLIER, BioTechniques, (19900000), vol. 9, no. 2, pages 142 - 148
    - FIREXU, Proceedings of the National Academy of Sciences, (19950000), vol. 92, no. 10, pages 4641 - 4645
    - COMPTON, Nature, (19910000), vol. 350, no. 6313, pages 91 - 92
    - VAN NESSVAN NESSGALAS, Proceedings of the National Academy of Sciences of the United States of America, (20030000), vol. 100, no. 8, pages 4504 - 4509
    - R. M. DIRKSPIERCE, Proceedings of the National Academy of Sciences of the United States of America, (20040000), vol. 101, no. 43, pages 15275 - 15278
    - LI, ELLINGTONCHEN, Nucleic Acids Research, (20110000), vol. 39, no. 16, page e110
    - SEELABUDOW, Molecular bioSystems, (20080000), vol. 4, no. 3, pages 232 - 245
    - KWOK et al., Nucleic Acids Research, (19900000), vol. 18, no. 4, pages 999 - 1005
    - STADHOUDERS et al., The Journal of Molecular Diagnostics: JMD, (20100000), vol. 12, no. 1, pages 109 - 117
    - ONOTOGASHI, Angewandte Chemie (International Ed. in English), (20040000), vol. 43, no. 33, pages 4300 - 4302
    - TORIGOE et al., Biochimie, (20120000), vol. 94, no. 11, pages 2431 - 2440
    - CORDIERPIERREBARTON, Journal of the American Chemical Society, (20070000), vol. 129, no. 40, pages 12287 - 12295
    - NAKATANISANDOKUMASAWAKIKUCHISAITO, Journal of the American Chemical Society, (20010000), vol. 123, no. 50, pages 12650 - 12657
    - MITSUHASHI, J. Clin. Lab. Anal., (19960000), vol. 10, no. 5, pages 285 - 93
    - VON EGGELING et al., Cell. Mol. Biol., (19950000), vol. 41, no. 5, pages 653 - 70
    - ZHANG et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 5847 - 5851
    - TELENIUS et al., Genomics, (19920000), vol. 13, no. 3, pages 718 - 25
    - LIZARDI, GUERRALOMELI, TUSSIE-LUNARUSSELL KRAMER, Nature Biotechnology, (19880000), vol. 6, no. 10, pages 1197 - 1202
    - LANDGREN, Trends in Genetics, (19930000), vol. 9, pages 199 - 202
    - "In Vitro Nucleic Acid Amplification Techniques", PERSING, DAVID H. et al., Diagnostic Medical Microbiology: Principles and Applications, American Society for Microbiology, (19930000), pages 51 - 87
    - Analyst, (20140000), vol. 139, pages 1644 - 1652
    - PNAS, (20030415), vol. 100, pages 4504 - 4509
    - Sci Rep, (20120000), vol. 2, page 246
    - Nature Methods, (20070400), vol. 4, no. 3, pages 257 - 62
    - Proceedings of the National Academy of Sciences, (20050000), vol. 102, no. 48, pages 17332 - 6
    - Journal of Clinical Virology, vol. 54, no. 4, pages 308 - 12
    - clinical chemistry, (20050000), vol. 51, no. 101973-1981
    - URDEA et al., Gene, (19870000), vol. 61, no. 3, pages 253 - 264
    - J. Am. Chem. Soc., (20130000), vol. 135, no. 20, pages 7430 - 7433
    - Biotechniques, (20020300), vol. 32, no. 3, pages 604 - 6,608-11
    - MACKAYARDENNITSCHE, Nucleic Acids Research, (20020000), vol. 30, no. 6, pages 1292 - 1305
    - ERNST et al., J. Am. Chem. Soc., (20090000), vol. 131, pages 2359 - 2366
    - OROSKAR et al., Clinical Chemistry, (19960000), vol. 42, no. 9, pages 1547 - 1555
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.